0001437749-22-012711.txt : 20220516
0001437749-22-012711.hdr.sgml : 20220516
20220516182120
ACCESSION NUMBER: 0001437749-22-012711
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220513
FILED AS OF DATE: 20220516
DATE AS OF CHANGE: 20220516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Remmel H. Lawrence
CENTRAL INDEX KEY: 0001551817
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35610
FILM NUMBER: 22931505
MAIL ADDRESS:
STREET 1: C/O ATOSSA GENETICS, INC.
STREET 2: 4105 MADISON STREET, SUITE 320
CITY: SEATTLE
STATE: WA
ZIP: 98112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001488039
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264753208
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
BUSINESS PHONE: 206.588.0256
MAIL ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
FORMER COMPANY:
FORMER CONFORMED NAME: ATOSSA GENETICS INC
DATE OF NAME CHANGE: 20100325
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-05-13
0001488039
ATOSSA THERAPEUTICS, INC.
ATOS
0001551817
Remmel H. Lawrence
C/O ATOSSA THERAPEUTICS, INC.,
107 SPRING STREET
SEATTLE
WA
98104
1
Stock Option (right to buy)
0.93
2022-05-13
4
A
0
50000
0
A
2032-05-13
Common Stock
50000
50000
D
The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:30 a.m. (ET) on May 13, 2022, with an exercise price of $0.93, representing the most recently reported closing stock price on May 12, 2022.
/s/ H. Lawrence Remmel
2022-05-16